⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Global Left Ventricular Assist Devices (LVAD) Market Size, Share, Trends, and Forecast, 2026-2036 | Market to Reach $6.08 Billion at 10% CAGR as Destination Therapy and AI Monitoring Expand
globenewswire.com
ABT
MDT
AMGN
JNJ
Pulsed Field Ablation (PFA) Market Size, Share, and Trends - Global Industry Forecast, 2026-2036 | Market Poised for 16.8% CAGR to $4.3 Billion as Cardiac Adoption and Oncology Opportunities Expand
globenewswire.com
BSX
JNJ
ABT
PLSE
ATRC
STKS
Argentina Data Center Market - Investment Analysis and Growth Opportunities 2026-2031 | AI and Cloud Demand Drive 16.27% CAGR, Lifting Market Value to USD 825 Million
globenewswire.com
NVDA
GOOG
MSFT
AMZN
IBM
INTC
AMD
HPE
DELL
CSCO
ACN
T
VZ
TMUS
EQIX
DLR
QCOM
AMAT
LRCX
MU
NXPI
ON
ADI
TXN
MRVL
SNPS
CDNS
PLTR
AI
UPST
CRSP
GILD
BIIB
REGN
MRNA
PFE
JNJ
BMY
ABBV
AMGN
VRTX
ILMN
ROKU
TSLA
NIO
RIVN
LCID
Neue Führungskräfte im Vertriebsbereich bei Neuromod
prnewswire.com
ATLC
JNJ
SONO
Angel Lee, CEO von PhytoHealth, für ihren Einsatz bei der Entwicklung des weltweit ersten verschreibungspflichtigen Medikaments gegen krebsbedingte Müdigkeit ausgezeichnet
prnewswire.com
JNJ
Angel Lee, reconocida por impulsar desarrollo del primer medicamento recetado para fatiga por cáncer
prnewswire.com
JNJ
Europe CAR-T Therapies Market for Autoimmune Disorders: Trends, Growth, and Forecast to 2035 | 47.4% CAGR Signals a USD 1.25 Billion Opportunity as Clinical Pipelines Advance
globenewswire.com
AUTL
KYMR
NVS
SANA
JNJ
Johnson & Johnson announces new ICOTYDE® (icotrokinra) data in difficult-to-treat plaque psoriasis with proven durability through 2-years, affirming its use as a powerful first line systemic therapy
prnewswire.com
JNJ
Global Adult and Baby Diaper Market 2026: Size, Share, Trends, and Forecast to 2030 | Market to Reach US$141.20 Billion as Sustainable Products and E-Commerce Drive Growth
globenewswire.com
PG
JNJ
KMB
Angel Lee, PDG de PhytoHealth, récompensé pour sa contribution au développement du premier médicament sur ordonnance au monde destiné à traiter la fatigue liée au cancer
prnewswire.com
JNJ